CN Stock MarketDetailed Quotes

603998 Hunan Fangsheng Pharmaceutical

Watchlist
  • 11.84
  • +0.02+0.17%
Market Closed May 31 15:00 CST
5.20BMarket Cap26.91P/E (TTM)

Hunan Fangsheng Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hunan Fangsheng Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 20, 2024

Revenue(YoY)

438.35M

+0.37%
EPS(YoY)

0.16

+6.67%
Analyst Rating

Strong Buy

Jun 1, 2024

Hunan Fangsheng Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.329B--
--2024/FY-- / 1.804B--
--2023/FY1.629B / 1.802B--
Mar 31, 20232022/FY1.792B / 1.877B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.329B--
--2024/FY-- / 1.804B--
--2023/FY1.629B / 1.802B--
Mar 31, 20232022/FY1.792B / 1.877B--

Hunan Fangsheng Pharmaceutical Earnings Reports

  • Summary of Fangsheng Pharmaceutical's 2023 Annual Report

    Apr 19 12:00 ET

  • Fangsheng Pharmaceutical's 2024 First Quarter Report

    Apr 19 12:00 ET

  • Fangsheng Pharmaceutical 2023 Annual Report

    Apr 19 12:00 ET

  • Fangsheng Pharmaceutical\'s report for the third quarter of 2023

    Oct 25, 2023 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 1, 2024

    Strong Buy

    • Strong Buy

      85.71%

    • Buy

      14.29%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg